EV/EBITDA
0.18
-0.02-10.00%
3 min ago
Summary
- As of February 26, 2025, CNSP EV/EBITDA is 0.18, with a fall of -0.02 (-10.00%) during the most recent trading day.
- Over the past year, CNSP EV/EBITDA has increased by +0.28 (+280.00%).
- CNSP EV/EBITDA is now -66.04% below its all-time high of 0.53.
Performance
CNSP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CNSP EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -10.0% | +6.7% | +6.2% |
| 1 m1 month | +400.0% | -410.6% | -51.9% |
| 3 m3 months | +800.0% | -1039.9% | -56.0% |
| 6 m6 months | +164.3% | -170.6% | -71.7% |
| ytdytd | +100.0% | -7037.6% | -57.5% |
| 1 y1 year | +280.0% | -265.4% | -99.6% |
| 5 y5 years | +101.4% | -106.3% | -100.0% |
CNSP EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -10.0% | -0.22 | +181.8% | |
| 3 m | 3-month | 0.20 | -10.0% | -0.22 | +181.8% |
| 6 m | 6-month | 0.20 | -10.0% | -0.31 | +158.1% |
| 1 y | 1-year | 0.20 | -10.0% | -0.31 | +158.1% |
| 3 y | 3-year | 0.53 | -66.0% | -0.71 | +125.3% |
| 5 y | 5-year | 0.53 | -66.0% | -13.77 | +101.3% |
| alltime | all time | 0.53 | -66.0% | -17.65 | +101.0% |
CNS Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.18(>+9900.0%) |
| 2024 | 0.00(-100.0%) |
| 2023 | -0.41(-202.5%) |
| Date | Value |
|---|---|
| 2022 | 0.40(-135.1%) |
| 2021 | -1.14(-59.3%) |
| 2020 | -2.80(-79.4%) |
| 2019 | -13.58 |
FAQ
- What is CNS Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for CNS Pharmaceuticals?
- What is CNSP EV/EBITDA year-to-date change?
- What is CNS Pharmaceuticals EV/EBITDA year-on-year change?
What is CNS Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of CNSP is 0.18
What is the all time high EV/EBITDA for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high EV/EBITDA is 0.53
What is CNSP EV/EBITDA year-to-date change?
CNS Pharmaceuticals EV/EBITDA has changed by +0.18 (+100.00%) since the beginning of the year
What is CNS Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, CNSP EV/EBITDA has changed by +0.28 (+280.00%)